Sort by
Refine Your Search
-
modeling, ligand docking and drug design to develop the next generation of safer anesthetics. Specifically, this individual will initially be an integral developer of a large series of homology models
-
and talented LSRP that has an interest in the basic science of stem cells, cardiovascular diseases and drug discovery. The project builds on recent initiatives at the Stanford University Cardiovascular
-
Cancer Clinical Research Coordinator Associate – Early Drug Development (Hybrid Position) The Clinical Trials Office in the Stanford Cancer Institute, in Stanford University’s School of Medicine
-
. Candidates should have a scientific background, a general familiarity with the process of drug discovery and development, and excellent time management and organizational skills. Candidates should be self
-
datasets to identify candidate exercise mimetic drugs (i.e. "exercise in a pill") 2. Development of cloud-based infrastructures for data browsing, interactivity, and discovery, in MoTrPAC and others 3
-
Drug Development (Hybrid Position) The Clinical Trials Office in the Stanford Cancer Institute, in Stanford University's School of Medicine seeks a Clinical Research Associate to perform duties related
-
center of its kind, aiming not only to find better treatments for children and adults with allergies and asthma, but to discover underlying immune mechanisms against the diseases and develop a lasting cure
-
processing of blood samples, reporting serious adverse events and maintenance of drug accountability, supplies and equipment. CV Med Clinical Research is a growing, dynamic team who is dedicated to supporting
-
socioeconomic backgrounds. The Center is aiming not only to find better treatments for children and adults with allergies and asthma, but to discover underlying immune mechanisms against the diseases and develop
-
and animal models. This project is part of National Heart Lung and Blood Institute (NHLBI) Catalyze program to develop technologies and transformative platforms supporting cardiovascular drug discovery